Security Snapshot

COMPASS Pathways plc - Ordinary Shares (CMPS) Institutional Ownership

CUSIP: 20451W101

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

168

Shares (Excl. Options)

54,978,360

Price

$6.90

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Ordinary Shares
Symbol
CMPS on Nasdaq
Shares outstanding
96,062,702
Price per share
$5.53
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
54,978,360
Total reported value
$379,240,230
% of total 13F portfolios
0%
Share change
-2,516,133
Value change
-$9,837,666
Number of holders
168
Price from insider filings
$5.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • CMPS - COMPASS Pathways plc - Ordinary Shares is tracked under CUSIP 20451W101.
  • 168 institutions reported positions in Q4 2025.
  • 10 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 168 to 63 between Q4 2025 and Q1 2026.
  • Reported value moved from $379,240,230 to $43,365,619.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 168 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 20451W101?
CUSIP 20451W101 identifies CMPS - COMPASS Pathways plc - Ordinary Shares in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of COMPASS Pathways plc - Ordinary Shares (CMPS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 9.9% +20% $34,865,781 +$5,877,137 9,474,397 +20% RTW Investments, LP 30 Jun 2025
Deep Track Capital, LP 10% $34,965,201 9,274,589 Deep Track Capital, LP 10 Jan 2025
ATAI Life Sciences N.V. 6% -19% $33,152,485 -$6,417,600 5,785,774 -16% ATAI Life Sciences N.V. 27 Oct 2025
AtaiBeckley Inc. 5% $37,260,032 4,764,710 AtaiBeckley Inc. 21 Jan 2026
TCG Crossover GP I, LLC 3.9% $14,197,440 3,858,000 Chen Yu 30 Jun 2025
Nantahala Capital Management, LLC 3.6% -44% $19,965,125 -$14,038,500 3,484,315 -41% Nantahala Capital Management, LLC 30 Sep 2025
Vivo Opportunity Fund Holdings, L.P. 3.2% -49% $18,189,851 -$18,189,851 3,174,494 -50% Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
INTEGRATED CORE STRATEGIES (US) LLC 3% -18% $10,456,174 -$2,412,525 2,773,521 -19% Millennium Management LLC 31 Mar 2025
Goldsmith George Jay 2.4% -6.7% $8,444,129 -$487,589 2,239,822 -5.5% George Jay Goldsmith 31 Mar 2025
CITADEL ADVISORS LLC 1.7% $4,397,992 1,166,576 Kenneth Griffin 31 Dec 2024

As of 31 Dec 2025, 168 institutional investors reported holding 54,978,360 shares of COMPASS Pathways plc - Ordinary Shares (CMPS). This represents 57% of the company’s total 96,062,702 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of COMPASS Pathways plc - Ordinary Shares (CMPS) together control 47% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RTW INVESTMENTS, LP 9.1% 8,757,390 +0.57% 0.61% $60,425,991
Deep Track Capital, LP 7.6% 7,334,323 -6.7% 1.2% $50,606,829
GMT CAPITAL CORP 3% 2,844,618 0% 1% $19,627,864
TORONTO DOMINION BANK 2.6% 2,529,013 +153% 0.03% $17,446,594
ARK Investment Management LLC 2.2% 2,156,012 +1.6% 0.1% $14,876,481
UBS Group AG 2.1% 2,038,444 -4.9% 0% $14,065,263
TWO SIGMA INVESTMENTS, LP 1.7% 1,644,242 +53% 0.02% $11,345,270
Jefferies Financial Group Inc. 1.6% 1,576,905 +15% 0.09% $10,880,645
Eagle Health Investments LP 1.6% 1,519,388 +62% 2.3% $10,483,777
D. E. Shaw & Co., Inc. 1.5% 1,453,876 +114% 0.01% $10,031,744
MILLENNIUM MANAGEMENT LLC 1.4% 1,387,658 -49% 0.01% $9,574,840
Aisling Capital Management LP 1.2% 1,198,418 0% 1.7% $8,269,084
MORGAN STANLEY 1.2% 1,137,520 +10% 0% $7,848,890
Siren, L.L.C. 1% 1,000,000 0.21% $6,900,000
RENAISSANCE TECHNOLOGIES LLC 1% 967,846 +1.8% 0.01% $6,678,137
Propel Bio Management, LLC 0.9% 861,778 +69% 5.1% $5,946,268
TWO SIGMA ADVISERS, LP 0.89% 856,500 +56% 0.01% $5,909,850
Point72 Asset Management, L.P. 0.88% 844,816 0.01% $5,829,230
Kalehua Capital Management LLC 0.85% 819,692 0% 5.7% $5,655,875
DAFNA Capital Management LLC 0.84% 811,046 0% 1.3% $5,596,217
PFM Health Sciences, LP 0.81% 779,618 -53% 0.54% $5,379,364
NEXTBio Capital Management LP 0.78% 752,631 0% 3% $5,193,154
AMERIPRISE FINANCIAL INC 0.67% 645,065 -47% 0% $4,450,948
BlackRock, Inc. 0.62% 594,269 +41% 0% $4,100,456
CenterBook Partners LP 0.6% 578,828 -9% 0.2% $3,993,913

Institutional Holders of COMPASS Pathways plc - Ordinary Shares (CMPS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 7,850,194 $43,365,619 +$1,597,798 $5.53 63
2025 Q4 54,978,360 $379,240,230 -$9,837,666 $6.90 168
2025 Q3 55,478,445 $317,956,932 +$43,716,633 $5.73 156
2025 Q2 51,583,152 $144,431,981 -$1,393,321 $2.80 138
2025 Q1 51,907,228 $148,440,425 +$56,948,835 $2.86 133
2024 Q4 30,929,042 $116,907,663 -$20,846,000 $3.78 128
2024 Q3 32,763,643 $206,367,035 +$27,403,973 $6.30 128
2024 Q2 28,409,803 $171,575,414 +$1,889,820 $6.04 116
2024 Q1 27,439,335 $227,960,097 +$39,222,122 $8.32 112
2023 Q4 22,952,328 $200,843,193 +$1,082,314 $8.75 121
2023 Q3 22,280,531 $164,869,713 +$104,007,721 $7.40 110
2023 Q2 8,294,747 $68,684,596 +$755,774 $8.28 94
2023 Q1 8,180,991 $81,262,630 +$5,919,312 $9.93 96
2022 Q4 7,596,486 $60,996,989 -$1,347,268 $8.03 100
2022 Q3 7,469,096 $80,193,999 +$6,774,033 $10.73 92
2022 Q2 6,824,644 $73,767,367 -$11,822,313 $10.82 86
2022 Q1 7,723,302 $99,547,423 -$8,010,808 $12.89 84
2021 Q4 7,545,637 $166,751,619 -$17,849,624 $22.10 109
2021 Q3 7,609,549 $227,364,277 -$10,697,423 $29.87 103
2021 Q2 7,724,088 $294,563,899 +$104,310,691 $38.15 102
2021 Q1 4,941,852 $181,943,613 -$36,356,466 $36.82 78
2020 Q4 5,817,136 $277,164,269 -$2,554,807 $47.64 54
2020 Q3 5,493,873 $192,316,000 +$192,278,000 $34.90 37
2020 Q2 1,000 $38,000 $38.00 1
2020 Q1 1,000 $38,000 $38.00 1
2019 Q4 1,000 $38,000 $38.00 1
2019 Q3 1,000 $38,000 $38.00 1
2019 Q2 1,000 $38,000 $38.00 1
2019 Q1 1,000 $38,000 $38.00 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .